(Q35849011)

English

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

scientific article published on 9 May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

aplastic anemia

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

13

object named as

Barry Storer

1 reference

Europe PubMed Central

10 August 2017

PMC publication ID

Hans Joachim Deeg

1

object named as

H Joachim Deeg

1 reference

Europe PubMed Central

10 August 2017

PMC publication ID

12

object named as

Ann Woolfrey

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Margaret O'Donnell

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Rajni Agarwal

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Richard E Harris

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Stephen A Feig

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Mary C Territo

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Robert H Collins

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Peter A McSweeney

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Edward A Copelan

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Shakila P Khan

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

9 May 2006

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

108

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1485-1491

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Improving availability and safety of unrelated donor transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Marrow transplantation for aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Marrow transplantation for severe aplastic anemia and thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

27 July 2018

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895515

24 September 2018

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Bl

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overproduction of inhibitory hematopoietic cytokines by lipopolysaccharide-activated peripheral blood mononuclear cells in patients with aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methods for assessment of graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16684959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2006-03-005041

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35849011&oldid=1746184674"